Health area
Heart & lipids
Cholesterol, triglycerides and the particles that carry them in the blood. Some of them, such as LDL cholesterol and apolipoprotein B, are linked with the risk of heart and blood vessel disease.
The Longevity Panel measures 20 markers in Heart & lipids. Each one is placed in its range in the app and explained, with the studies behind it.
What we measure
Apolipoprotein B (ApoB)
mg/dLApoB mass concentration is a surrogate for the number of plaque-forming lipoprotein particles in your blood. When ApoB and LDL cholesterol disagree, ApoB predicts risk better — and it can stay high while LDL looks reassuring.
Lp(a)
nmol/LLipoprotein(a) — an LDL-like particle whose level is set almost entirely by your genes and barely shifts with diet or exercise. It independently drives heart-attack and aortic-valve risk, and measuring it once establishes your lifetime baseline.
Omega-3 Index
%The share of EPA plus DHA in your red-cell membranes — a stable readout of omega-3 status over the past few months rather than of your last meal. It moves gradually as omega-3 intake changes, over weeks rather than days.
LDL cholesterol, directly measured
mg/dLLDL cholesterol measured directly by the lab rather than calculated from your other lipids. The calculated version loses accuracy when triglycerides are high or you did not fast; this one does not.
PREVENT 10-year Cardiovascular Risk
%Calculated from your values · From age 30 to 79
A calculated estimate, not a blood measurement, of your chance of a heart attack, stroke or heart failure over the next 10 years, in percent. It is the American Heart Association's PREVENT model for adults aged 30 to 79 without heart disease, built and tested on US adults.
SCORE2 10-year Cardiovascular Risk
%Calculated from your values · From age 40 to 69
A calculated estimate, not a blood measurement, of a person's chance of having a heart attack or stroke over the next 10 years, expressed as a percentage. It succeeds the earlier SCORE system and is built from conventional cardiovascular risk factors.
Triglycerides
mg/dLThe main fat carried in your blood, packaged into particles by the gut after a meal and by the liver between meals. Levels move sharply with recent food and alcohol, so a fasting sample matters; very high values also raise the risk of pancreatitis.
Homocysteine
µmol/LAn amino acid that accumulates when B12, folate or B6 run short, or when kidney function declines. It is associated with cardiovascular and cognitive risk, though lowering it with B vitamins has not reduced cardiovascular events in trials.
TG/HDL Ratio
ratioCalculated from your values
The triglyceride-to-HDL ratio is a powerful proxy for insulin resistance, small dense LDL particle count, and metabolic syndrome. Optimal: below 0.87 (mmol/L units) or below 2.0 (mg/dL units).
Atherogenic Index of Plasma (AIP)
indexCalculated from your values
The Atherogenic Index of Plasma (AIP) is log₁₀(TG/HDL) and is more sensitive than the simple TG/HDL ratio for predicting coronary artery disease. AIP < 0.11 is low risk; 0.11–0.21 intermediate; >0.21 high risk.
Non-HDL Cholesterol
mg/dLCalculated from your values
Non-HDL cholesterol captures all atherogenic lipoproteins (LDL + VLDL + IDL + Lp(a) fraction) in a single value. ESC guidelines recommend it alongside ApoB as a superior alternative to LDL-C alone. Target: below 3.4 mmol/L (130 mg/dL).
Castelli Risk Index I
ratioCalculated from your values
The Castelli Risk Index I (Total Cholesterol / HDL) is a Framingham Heart Study–validated predictor of cardiovascular events. Optimal below 4.0 in men and below 3.5 in women.
Castelli Risk Index II (LDL/HDL)
ratioCalculated from your values
The Castelli Risk Index II (LDL / HDL) is an independent cardiovascular predictor beyond absolute LDL or HDL values. Optimal below 3.0; high risk above 4.0.
LDL Cholesterol
mg/dLCalculated from your values
The cholesterol carried in LDL particles, and the most firmly established causal driver of arterial plaque — lowering it lowers cardiovascular risk in trials. ApoB counts the particles more precisely, but LDL appears on every lab report.
HDL Cholesterol
mg/dLThe cholesterol carried in HDL particles, which move cholesterol back to the liver. Low HDL is a reliable marker of risk, but trials that raised it did not reduce events — so it reads as a signal rather than as something to push up.
Total Cholesterol
mg/dLThe sum of the cholesterol carried in all lipoprotein particles. Too coarse to guide decisions alone, since it adds plaque-driving and non-driving particles into one number; ApoB and non-HDL cholesterol separate them.
NT-proBNP
pg/mLNT-proBNP is a hormone released by the heart when it is under increased stress or pressure, such as in heart failure. Elevated levels indicate reduced cardiac function and are used to diagnose and monitor heart conditions.
Apolipoprotein A1 (ApoA1)
g/LApolipoprotein A1, the main structural protein of HDL particles. It tracks closely with HDL cholesterol, and treatments that raised this side of the lipid picture have not lowered cardiovascular events — so it reads as a risk marker rather than a target. Unlike ApoB it does not count particles, since each HDL particle carries several copies.
ApoB/ApoA1 Ratio
ratioCalculated from your values
The balance between the particles that drive artery plaque (ApoB) and the ones that carry cholesterol back out (ApoA1) — one of the strongest single lipid predictors of heart attack risk. Lower is better.
Remnant Cholesterol
mg/dLCalculated from your values
Cholesterol carried in triglyceride-rich particles, calculated as total cholesterol minus HDL minus LDL — the same arithmetic a lab reports as VLDL cholesterol. It is an independent driver of arterial plaque, and it responds to weight loss, less alcohol and fewer refined carbohydrates.
120 markers for every adult, in one visit.
Heart & lipids is one of 14 health areas in the Longevity Panel, together with three blood clocks, at one price.